Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01605747 · ClinicalTrials.gov registry record · Phase 2
Study of Culturelle in the Prophylaxis of Infection and Diarrhea
A Phase 2 study, sponsored by Shriners Hospitals for Children.
- Terminated
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT01605747 is a Phase 2 study that was terminated before completion, run by Shriners Hospitals for Children. The registered enrollment target is 20 participants.
The verdict
NCT01605747, a Phase 2 study, was terminated before completion, sponsored by Shriners Hospitals for Children.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
The primary objective of this study is to determine if probiotic prophylaxis has immunologic and gastrointestinal advantages in pediatric burn patients.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Culturelle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2011-01 |
| Est. Completion | 2015-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01605747
The ClinicalTrials.gov registry entry for NCT01605747 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shriners Hospitals for Children, which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01605747 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01605747 about?
NCT01605747 is a clinical study titled "Study of Culturelle in the Prophylaxis of Infection and Diarrhea". The primary objective of this study is to determine if probiotic prophylaxis has immunologic and gastrointestinal advantages in pediatric burn patients.
What is the current status of trial NCT01605747?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2011-01. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01605747?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Culturelle (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01605747?
This trial is sponsored by Shriners Hospitals for Children, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.